NeuroSense Therapeutics, led by CEO and founder Alon Ben-Noon, is tackling ALS and other neurological disorders with a bold, multi-targeted approach. Fueled...
Are you familiar with the devastating impact that neurodegenerative, autoimmune, and metabolic diseases can have on patients’ lives? These conditions often leave...